首页 > 最新文献

Expert review of respiratory medicine最新文献

英文 中文
An overview of the importance of allied healthcare for patients with COPD. 慢性阻塞性肺病患者联合医疗保健重要性概述
IF 2.7 Pub Date : 2026-02-09 DOI: 10.1080/17476348.2026.2629007
Sarah Houben-Wilke, Anouk W Vaes, Mara Cuijpers, Gwen Diederen, Sandra Evertse, Jérôme Jansen, Kristel Loven, Paula van Melick, Roy Meys, Rein Posthuma, Maurice J Sillen, Stephanie Ubachs-van Zandvoort, Frits Franssen, Alex van 't Hul, Martijn A Spruit

Introduction: Despite optimal pharmacological treatment, patients with COPD often experience symptoms and report physical, mental and/or social limitations. This underlines the need for additional, non-pharmacological interventions, such as physical therapy, psychological support, nutritional counseling and occupational therapy. In this, allied healthcare professionals (AHPs) play a vital role as they bring specialized knowledge and skills to assess and, if needed, treat different aspects of the disease. Areas covered: A broad literature search was conducted to narratively summarize current evidence of allied healthcare, underlines the importance of interprofessional collaboration, including the role of patients, and highlights future perspectives.

Expert opinion: The evidence of the important role of AHPs in the assessment and treatment of COPD is robust. Unfortunately, allied healthcare is markedly underutilized in patients with COPD. Increasing referral rates to AHPs is essential to optimize COPD management. Collaboration, including the role of the patient, is essential to ensure comprehensive and holistic care, improve outcomes and enhance communication. In the future, AHPs will be challenged to dare to think beyond their own expertise and expand their scope.

尽管有最佳的药物治疗,慢性阻塞性肺病患者经常出现症状,并报告身体、精神和/或社会限制。这强调需要额外的非药物干预措施,如物理治疗、心理支持、营养咨询和职业治疗。在这方面,联合医疗保健专业人员(ahp)发挥着至关重要的作用,因为他们提供专业知识和技能来评估并在需要时治疗疾病的不同方面。涵盖领域:进行了广泛的文献检索,以叙述性地总结了联合医疗保健的当前证据,强调了跨专业合作的重要性,包括患者的角色,并强调了未来的前景。专家意见:ahp在COPD评估和治疗中的重要作用的证据是强有力的。不幸的是,联合医疗保健在COPD患者中明显未得到充分利用。提高ahp的转诊率对于优化COPD管理至关重要。协作,包括患者的作用,对于确保全面和整体护理、改善结果和加强沟通至关重要。在未来,ahp将面临挑战,他们要敢于超越自己的专业知识,扩大自己的范围。
{"title":"An overview of the importance of allied healthcare for patients with COPD.","authors":"Sarah Houben-Wilke, Anouk W Vaes, Mara Cuijpers, Gwen Diederen, Sandra Evertse, Jérôme Jansen, Kristel Loven, Paula van Melick, Roy Meys, Rein Posthuma, Maurice J Sillen, Stephanie Ubachs-van Zandvoort, Frits Franssen, Alex van 't Hul, Martijn A Spruit","doi":"10.1080/17476348.2026.2629007","DOIUrl":"https://doi.org/10.1080/17476348.2026.2629007","url":null,"abstract":"<p><strong>Introduction: </strong>Despite optimal pharmacological treatment, patients with COPD often experience symptoms and report physical, mental and/or social limitations. This underlines the need for additional, non-pharmacological interventions, such as physical therapy, psychological support, nutritional counseling and occupational therapy. In this, allied healthcare professionals (AHPs) play a vital role as they bring specialized knowledge and skills to assess and, if needed, treat different aspects of the disease. Areas covered: A broad literature search was conducted to narratively summarize current evidence of allied healthcare, underlines the importance of interprofessional collaboration, including the role of patients, and highlights future perspectives.</p><p><strong>Expert opinion: </strong>The evidence of the important role of AHPs in the assessment and treatment of COPD is robust. Unfortunately, allied healthcare is markedly underutilized in patients with COPD. Increasing referral rates to AHPs is essential to optimize COPD management. Collaboration, including the role of the patient, is essential to ensure comprehensive and holistic care, improve outcomes and enhance communication. In the future, AHPs will be challenged to dare to think beyond their own expertise and expand their scope.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146145312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The double threat: bacterial and fungal co-/superinfection in viral pneumonia. 双重威胁:病毒性肺炎中的细菌和真菌共感染/重复感染。
IF 2.7 Pub Date : 2026-02-07 DOI: 10.1080/17476348.2026.2629003
Arsah Asis, Alejandro Rodríguez, Luis Felipe Reyes, Emili Díaz, Saad Nseir, Ignacio Martín-Loeches

Introduction: Respiratory viral pneumonias are a leading cause of severe respiratory failure and intensive care unit (ICU) admission worldwide. Although viral infection itself drives significant morbidity and mortality, secondary bacterial and fungal superinfections represent a critical 'double threat' in critically ill adults, exacerbating lung injury, prolonging organ dysfunction, and complicating antimicrobial management. Experience from the Influenza A (H1N1) pdm09 and SARS-CoV-2 pandemics highlights a persistent mismatch between low documented bacterial co-infection rates and widespread empiric antibiotic exposure, underscoring diagnostic uncertainty and antimicrobial stewardship challenges in the ICU.

Areas covered: This review examines the epidemiology, immunopathogenesis, and diagnostic approaches to bacterial and fungal superinfection in adult ICU patients with severe viral pneumonia. Evidence is synthesized from large ICU cohorts, pandemic data, and established consensus definitions for influenza- and COVID-19-associated pulmonary aspergillosis (IAPA, CAPA). The review discusses advances in molecular diagnostics, lower respiratory tract sampling, bronchoalveolar lavage - based mycology, and biomarker-guided strategies, with a focused literature search of ICU-specific studies.

Expert opinion: Bacterial and fungal superinfections, while infrequent, carry substantial clinical impact in severe viral pneumonia. A multimodal, ICU-adapted diagnostic strategy integrating pathogen detection with host-response assessment is essential to support timely therapy, enable antimicrobial de-escalation, and align superinfection management with stewardship principles.

呼吸道病毒性肺炎是全球严重呼吸衰竭和重症监护病房(ICU)住院的主要原因。虽然病毒感染本身会导致显著的发病率和死亡率,但继发性细菌和真菌重复感染对危重成人来说是一种严重的“双重威胁”,会加剧肺损伤,延长器官功能障碍,并使抗菌药物管理复杂化。甲型H1N1流感pdm09和SARS-CoV-2大流行的经验突出了低记录细菌合并感染率与广泛的经验性抗生素暴露之间的持续不匹配,突出了ICU诊断的不确定性和抗菌药物管理方面的挑战。涉及领域:本文综述了重症病毒性肺炎成人ICU患者细菌和真菌重复感染的流行病学、免疫发病机制和诊断方法。证据综合了大型ICU队列、大流行数据以及流感和covid -19相关肺曲霉病(IAPA, CAPA)的既定共识定义。本文讨论了分子诊断、下呼吸道采样、支气管肺泡灌洗真菌学和生物标志物引导策略的进展,并重点介绍了icu特异性研究的文献检索。专家意见:细菌和真菌的重复感染虽然不常见,但对严重的病毒性肺炎有重大的临床影响。采用多模式、适合重症监护病房的诊断策略,将病原体检测与宿主反应评估结合起来,对于支持及时治疗、实现抗微生物药物降级以及使重复感染管理与管理原则保持一致至关重要。
{"title":"The double threat: bacterial and fungal co-/superinfection in viral pneumonia.","authors":"Arsah Asis, Alejandro Rodríguez, Luis Felipe Reyes, Emili Díaz, Saad Nseir, Ignacio Martín-Loeches","doi":"10.1080/17476348.2026.2629003","DOIUrl":"https://doi.org/10.1080/17476348.2026.2629003","url":null,"abstract":"<p><strong>Introduction: </strong>Respiratory viral pneumonias are a leading cause of severe respiratory failure and intensive care unit (ICU) admission worldwide. Although viral infection itself drives significant morbidity and mortality, secondary bacterial and fungal superinfections represent a critical 'double threat' in critically ill adults, exacerbating lung injury, prolonging organ dysfunction, and complicating antimicrobial management. Experience from the Influenza A (H1N1) pdm09 and SARS-CoV-2 pandemics highlights a persistent mismatch between low documented bacterial co-infection rates and widespread empiric antibiotic exposure, underscoring diagnostic uncertainty and antimicrobial stewardship challenges in the ICU.</p><p><strong>Areas covered: </strong>This review examines the epidemiology, immunopathogenesis, and diagnostic approaches to bacterial and fungal superinfection in adult ICU patients with severe viral pneumonia. Evidence is synthesized from large ICU cohorts, pandemic data, and established consensus definitions for influenza- and COVID-19-associated pulmonary aspergillosis (IAPA, CAPA). The review discusses advances in molecular diagnostics, lower respiratory tract sampling, bronchoalveolar lavage - based mycology, and biomarker-guided strategies, with a focused literature search of ICU-specific studies.</p><p><strong>Expert opinion: </strong>Bacterial and fungal superinfections, while infrequent, carry substantial clinical impact in severe viral pneumonia. A multimodal, ICU-adapted diagnostic strategy integrating pathogen detection with host-response assessment is essential to support timely therapy, enable antimicrobial de-escalation, and align superinfection management with stewardship principles.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airway clearance techniques - a proposed classification based on definitions? 气道清除技术-基于定义的拟议分类?
IF 2.7 Pub Date : 2026-02-05 DOI: 10.1080/17476348.2026.2626079
Gregory Reychler, Nicolas Audag, Guillaume Prieur, William Poncin, Olivier Contal

Introduction: Airway clearance techniques (ACT) are a longstanding modality of treatment in many chronic respiratory diseases. Their aims are to counteract airway obstruction by mobilizing airway secretions and/or by limiting the airway collapse.

Areas covered: This review first outlines the physiological mechanisms underlying ACT. In a second part, it categorizes the ACT into seven distinct groups. These groups include both instrumental and non-instrumental ACT. Strategies such as physical activity and upper airway clearance techniques are also considered as ACT due to their complementary roles in mobilizing airway secretions.

Expert opinion: The lack of standardized definitions for airway clearance techniques (ACT) leads to significant differences in the clinical practice and effects because the variability in physiological mechanisms. Studies show that both manual and instrumental ACT are influenced by therapist-dependent factors such as applied force, duration of the application, and patient positioning. To ensure reproducibility and effective teaching, a single, physiologically grounded description of ACT is urgently needed.

导论:气道清除技术(ACT)是许多慢性呼吸系统疾病的长期治疗方式。其目的是通过动员气道分泌物和/或限制气道塌陷来抵消气道阻塞。涵盖领域:本文首先概述了ACT的生理机制。在第二部分,它将ACT分为七个不同的组。这些组包括工具性和非工具性ACT。身体活动和上呼吸道清除技术等策略也被认为是ACT,因为它们在动员气道分泌物方面具有互补作用。专家意见:由于生理机制的差异,气道清除技术(ACT)缺乏标准化的定义,导致临床实践和效果存在显著差异。研究表明,手工和器械ACT都受到治疗师依赖因素的影响,如施加力、施加力持续时间和患者体位。为了确保教学的可重复性和有效性,迫切需要对ACT进行单一的、基于生理学的描述。
{"title":"Airway clearance techniques - a proposed classification based on definitions?","authors":"Gregory Reychler, Nicolas Audag, Guillaume Prieur, William Poncin, Olivier Contal","doi":"10.1080/17476348.2026.2626079","DOIUrl":"https://doi.org/10.1080/17476348.2026.2626079","url":null,"abstract":"<p><strong>Introduction: </strong>Airway clearance techniques (ACT) are a longstanding modality of treatment in many chronic respiratory diseases. Their aims are to counteract airway obstruction by mobilizing airway secretions and/or by limiting the airway collapse.</p><p><strong>Areas covered: </strong>This review first outlines the physiological mechanisms underlying ACT. In a second part, it categorizes the ACT into seven distinct groups. These groups include both instrumental and non-instrumental ACT. Strategies such as physical activity and upper airway clearance techniques are also considered as ACT due to their complementary roles in mobilizing airway secretions.</p><p><strong>Expert opinion: </strong>The lack of standardized definitions for airway clearance techniques (ACT) leads to significant differences in the clinical practice and effects because the variability in physiological mechanisms. Studies show that both manual and instrumental ACT are influenced by therapist-dependent factors such as applied force, duration of the application, and patient positioning. To ensure reproducibility and effective teaching, a single, physiologically grounded description of ACT is urgently needed.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146128081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of anxiety, depression, fatigue, and social isolation in patients with bronchiectasis. 焦虑、抑郁、疲劳和社会隔离对支气管扩张患者的影响
IF 2.7 Pub Date : 2026-02-05 DOI: 10.1080/17476348.2026.2624864
Abebaw Mengistu Yohannes, Pooja Arora, George Marty Solomon
{"title":"Impact of anxiety, depression, fatigue, and social isolation in patients with bronchiectasis.","authors":"Abebaw Mengistu Yohannes, Pooja Arora, George Marty Solomon","doi":"10.1080/17476348.2026.2624864","DOIUrl":"10.1080/17476348.2026.2624864","url":null,"abstract":"","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"1-4"},"PeriodicalIF":2.7,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of central sleep apnea with heart failure. 中枢性睡眠呼吸暂停伴心力衰竭的综述。
IF 2.7 Pub Date : 2026-02-02 DOI: 10.1080/17476348.2026.2623999
Aymen Jmai, Sandhya Matthes, Winfried Randerath

Introduction: Central sleep apnea (CSA) affects up to one-third of patients with heart failure (HF) and is linked to sympathetic activation, arrhythmias, impaired quality of life, and worse prognosis. Understanding epidemiology, mechanisms, and evolving therapies is essential as management recommendations are rapidly changing.

Areas covered: This review synthesizes data retrieved from a PubMed database search on CSA prevalence across HF phenotypes, delineates pathophysiology, and appraises therapies. We performed a structured search for randomized trials, large observational studies, meta-analyses, and recent guidance, with focused appraisal of the latest statements from the American Academy of Sleep Medicine (AASM) and the European Respiratory Society (ERS).

Expert opinion: The field is shifting from one size fits all apnea-hyponea index (AHI) suppression to phenotype-guided care, prioritizing patient centered and cardiac outcomes. Integrating endotyping, remote monitoring, and HF co-management is key. Major gaps include optimal patient selection, long-term cardiovascular endpoints, and harmonization of guideline recommendations. If optimization of HF therapy and a continuous positive airway pressure (CPAP) trial fail to improve symptoms, adaptive servoventilation (ASV) becomes the preferred therapeutical option.

中枢性睡眠呼吸暂停(CSA)影响多达三分之一的心力衰竭(HF)患者,并与交感神经激活、心律失常、生活质量受损和预后不良有关。了解流行病学、机制和不断发展的治疗方法是必不可少的,因为管理建议正在迅速变化。涵盖领域:本综述综合了从PubMed数据库检索到的关于HF表型中CSA患病率的数据,描述了病理生理学,并评估了治疗方法。我们对随机试验、大型观察性研究、荟萃分析和近期指南进行了结构化搜索,重点评估了美国睡眠医学学会(AASM)和欧洲呼吸学会(ERS)的最新声明。专家意见:该领域正在从一刀切的AHI抑制转变为以患者为中心和心脏结果优先的表型指导护理。整合内皮分型、远程监测和心衰共同管理是关键。主要的差距包括最佳患者选择、长期心血管终点和指南建议的统一。如果优化心衰治疗和持续气道正压通气(CPAP)试验未能改善症状,适应性伺服通气(ASV)成为首选的治疗选择。
{"title":"An overview of central sleep apnea with heart failure.","authors":"Aymen Jmai, Sandhya Matthes, Winfried Randerath","doi":"10.1080/17476348.2026.2623999","DOIUrl":"10.1080/17476348.2026.2623999","url":null,"abstract":"<p><strong>Introduction: </strong>Central sleep apnea (CSA) affects up to one-third of patients with heart failure (HF) and is linked to sympathetic activation, arrhythmias, impaired quality of life, and worse prognosis. Understanding epidemiology, mechanisms, and evolving therapies is essential as management recommendations are rapidly changing.</p><p><strong>Areas covered: </strong>This review synthesizes data retrieved from a PubMed database search on CSA prevalence across HF phenotypes, delineates pathophysiology, and appraises therapies. We performed a structured search for randomized trials, large observational studies, meta-analyses, and recent guidance, with focused appraisal of the latest statements from the American Academy of Sleep Medicine (AASM) and the European Respiratory Society (ERS).</p><p><strong>Expert opinion: </strong>The field is shifting from one size fits all apnea-hyponea index (AHI) suppression to phenotype-guided care, prioritizing patient centered and cardiac outcomes. Integrating endotyping, remote monitoring, and HF co-management is key. Major gaps include optimal patient selection, long-term cardiovascular endpoints, and harmonization of guideline recommendations. If optimization of HF therapy and a continuous positive airway pressure (CPAP) trial fail to improve symptoms, adaptive servoventilation (ASV) becomes the preferred therapeutical option.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"1-18"},"PeriodicalIF":2.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146088681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive surgical approaches for pneumothorax: evolution and current perspectives. 气胸的微创手术入路:发展和目前的观点。
IF 2.7 Pub Date : 2026-02-01 Epub Date: 2025-09-11 DOI: 10.1080/17476348.2025.2559439
Teruaki Mizobuchi, Yuki Ito, Akimu Sobue, Yuki Tada, Kaoru Nagato, Takayoshi Yamamoto

Introduction: PubMed was used for a literature search (1990-2025) on the minimally invasive surgical approaches for pneumothorax, which have evolved markedly, with video-assisted thoracic surgery (VATS) emerging as a preferred procedure. Systematic reviews of randomized control trials indicate that VATS is less invasive than traditional thoracotomy. Furthermore, uniportal VATS provides less postoperative pain and better cosmetic outcomes than thoracotomy. Currently, uniportal VATS seems preferred as the minimally invasive surgical approach for pneumothorax. New devices such as small-diameter thoracoscopes and forceps, which are used in uniportal subxiphoid VATS and uniportal subcostal robot-assisted thoracic surgery, may contribute to reducing the postoperative incidence of intercostal neuralgia and enhancing satisfaction with the cosmetic results.

Areas covered: The ideal surgical approaches for pneumothorax, referencing guidelines, and studies from various countries.

Expert opinion: This review explores various aspects of minimally invasive surgical approaches for pneumothorax. Uniportal VATS for pneumothorax via the intercostal approach is commonly performed worldwide and ensures high surgical quality. This review discusses what should be performed within the thoracic cavity to reduce the postoperative recurrence rate of pneumothorax, problems associated with thoracic adhesions that may be disadvantageous for pneumothorax patients in the future, and the latest surgical approaches that may become mainstream.

简介:PubMed检索了关于气胸微创手术入路的文献(1990-2025),这些手术方式有了显著的发展,视频辅助胸外科手术(VATS)成为首选手术方式。随机对照试验的系统评价表明,VATS比传统的开胸手术侵入性更小。此外,与开胸手术相比,单门VATS术后疼痛更少,美容效果更好。目前,单门VATS似乎是治疗气胸的首选微创手术方法。应用于单门静脉剑突下VATS和单门静脉肋下机器人辅助胸外科手术的新型器械如小直径胸腔镜和手术钳,可能有助于减少术后肋间神经痛的发生率,提高对美容效果的满意度。涵盖的领域:气胸的理想手术入路,参考指南,以及各国的研究。专家意见:本综述探讨了气胸微创手术入路的各个方面。经肋间入路的单门VATS治疗气胸在世界范围内普遍应用,确保了高手术质量。本文将讨论如何在胸腔内进行手术以降低气胸术后复发率、可能对气胸患者不利的胸粘连相关问题以及可能成为主流的最新手术入路。
{"title":"Minimally invasive surgical approaches for pneumothorax: evolution and current perspectives.","authors":"Teruaki Mizobuchi, Yuki Ito, Akimu Sobue, Yuki Tada, Kaoru Nagato, Takayoshi Yamamoto","doi":"10.1080/17476348.2025.2559439","DOIUrl":"10.1080/17476348.2025.2559439","url":null,"abstract":"<p><strong>Introduction: </strong>PubMed was used for a literature search (1990-2025) on the minimally invasive surgical approaches for pneumothorax, which have evolved markedly, with video-assisted thoracic surgery (VATS) emerging as a preferred procedure. Systematic reviews of randomized control trials indicate that VATS is less invasive than traditional thoracotomy. Furthermore, uniportal VATS provides less postoperative pain and better cosmetic outcomes than thoracotomy. Currently, uniportal VATS seems preferred as the minimally invasive surgical approach for pneumothorax. New devices such as small-diameter thoracoscopes and forceps, which are used in uniportal subxiphoid VATS and uniportal subcostal robot-assisted thoracic surgery, may contribute to reducing the postoperative incidence of intercostal neuralgia and enhancing satisfaction with the cosmetic results.</p><p><strong>Areas covered: </strong>The ideal surgical approaches for pneumothorax, referencing guidelines, and studies from various countries.</p><p><strong>Expert opinion: </strong>This review explores various aspects of minimally invasive surgical approaches for pneumothorax. Uniportal VATS for pneumothorax via the intercostal approach is commonly performed worldwide and ensures high surgical quality. This review discusses what should be performed within the thoracic cavity to reduce the postoperative recurrence rate of pneumothorax, problems associated with thoracic adhesions that may be disadvantageous for pneumothorax patients in the future, and the latest surgical approaches that may become mainstream.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"149-157"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Home-based pulmonary rehabilitation and health coaching in fibrotic interstitial lung disease: a perspective on current evidence and future directions. 纤维化间质性肺疾病的家庭肺康复和健康指导:当前证据和未来方向的观点
IF 2.7 Pub Date : 2026-02-01 Epub Date: 2025-07-25 DOI: 10.1080/17476348.2025.2539540
Teng Moua, Roberto Benzo

Introduction: The fibrotic interstitial lung diseases (f-ILD) are often progressive and debilitating lung diseases with significant symptom burden and impaired quality of life. Pulmonary rehabilitation (PR) has demonstrated improvements in dyspnea, physical function, and respiratory-related quality of life (RR-QoL) in patients with -f-ILD but had limited uptake and completion in real-world settings.

Areas covered: A literature review was completed on the impact and limitations of traditional PR in f-ILD, with additional perspective on the use of home-based approaches and implementation of health coaching. Barriers to traditional center-based PR programs include patient and systems-based factors such as unawareness of benefit, emotional or psychological distress, and limited access. Home-based PR may address these limitations by removing travel barriers, increasing access with remote supervision and monitoring, and promoting social support by connecting care with familiar settings. Studies involving home-based PR in ILD have shown promise with improving functional and quality of life outcomes and high compliance rates. Health coaching is a collaborative paradigm for fostering behavior change and has demonstrated positive impact in the management of chronic diseases.

Expert opinion: A combination of health coaching with home-based PR may address ongoing challenges of PR uptake and compliance as well as expand PR as a holistic and comprehensive intervention.

简介:纤维化间质性肺疾病(f-ILD)是一种进行性和衰弱性肺疾病,具有显著的症状负担和生活质量受损。肺康复(PR)已证明可改善-f-ILD患者的呼吸困难、身体功能和呼吸相关生活质量(RR-QoL),但在现实环境中摄取和完成程度有限。涵盖领域:完成了一项关于传统PR在f-ILD中的影响和局限性的文献综述,并对家庭方法的使用和健康指导的实施进行了额外的看法。传统的以中心为基础的公共关系项目的障碍包括基于患者和系统的因素,如没有意识到益处,情绪或心理困扰,以及有限的访问。以家庭为基础的公共关系可以消除旅行障碍,增加远程监督和监测的机会,并通过将护理与熟悉的环境联系起来促进社会支持,从而解决这些限制。涉及家庭PR治疗ILD的研究已经显示出改善功能和生活质量以及高依从率的希望。健康指导是一种促进行为改变的合作模式,并已证明对慢性疾病的管理有积极影响。专家意见:将健康指导与家庭公共关系相结合,可以解决公共关系吸收和遵守方面的持续挑战,并将公共关系扩展为一种整体和全面的干预措施。
{"title":"Home-based pulmonary rehabilitation and health coaching in fibrotic interstitial lung disease: a perspective on current evidence and future directions.","authors":"Teng Moua, Roberto Benzo","doi":"10.1080/17476348.2025.2539540","DOIUrl":"10.1080/17476348.2025.2539540","url":null,"abstract":"<p><strong>Introduction: </strong>The fibrotic interstitial lung diseases (f-ILD) are often progressive and debilitating lung diseases with significant symptom burden and impaired quality of life. Pulmonary rehabilitation (PR) has demonstrated improvements in dyspnea, physical function, and respiratory-related quality of life (RR-QoL) in patients with -f-ILD but had limited uptake and completion in real-world settings.</p><p><strong>Areas covered: </strong>A literature review was completed on the impact and limitations of traditional PR in f-ILD, with additional perspective on the use of home-based approaches and implementation of health coaching. Barriers to traditional center-based PR programs include patient and systems-based factors such as unawareness of benefit, emotional or psychological distress, and limited access. Home-based PR may address these limitations by removing travel barriers, increasing access with remote supervision and monitoring, and promoting social support by connecting care with familiar settings. Studies involving home-based PR in ILD have shown promise with improving functional and quality of life outcomes and high compliance rates. Health coaching is a collaborative paradigm for fostering behavior change and has demonstrated positive impact in the management of chronic diseases.</p><p><strong>Expert opinion: </strong>A combination of health coaching with home-based PR may address ongoing challenges of PR uptake and compliance as well as expand PR as a holistic and comprehensive intervention.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"121-131"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144700745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of strength training in patients with COPD: a systematic review. 力量训练对慢性阻塞性肺病患者的影响:一项系统综述。
IF 2.7 Pub Date : 2026-02-01 Epub Date: 2025-09-23 DOI: 10.1080/17476348.2025.2562638
María Barreiro Blanco, Clara Rodríguez-Gude, Iria Da Cuña-Carrera, Eva Lantarón-Caeiro

Introduction: Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms causing persistent, often progressive airflow obstruction. Strength training is a therapeutic option to prevent and/or reverse muscle dysfunction in COPD patients. Objective: to analyze the literature on the effects of strength training in COPD patients.

Methods: A systematic review from the last ten years was conducted in August 2024 across PubMed, Scopus, WOS, Medline and CINAHL databases. The search included studies examining resistance training for upper and lower limbs. Methodological quality was analyzed using the PEDro scale and the RoB2 was used for risk of bias.

Results: Six randomized controlled trials were eligible for inclusion, obtaining an excellent or good methodological quality. Most repeated variables were exercise capacity, quality of life and muscle strength, finding statistically significant positive results in all of them.

Conclusions: Strength training appears to be safe and effective for COPD treatment, with improvements in exercise capacity, activities of daily living, muscle strength, lung function, quality of life and inflammatory levels. However, scientific evidence on this topic is scarce, and future high-quality, long-term studies are necessary to establish standardized protocols and assess the sustained benefits of strength training in COPD patients.Protocol registration: Identifier is CRD42024572717.

慢性阻塞性肺疾病(COPD)是一种异质性肺部疾病,其特征是慢性呼吸道症状,导致持续的,通常是进行性气流阻塞。力量训练是COPD患者预防和/或逆转肌肉功能障碍的一种治疗选择。目的:分析COPD患者力量训练效果的文献。方法:于2024年8月对PubMed、Scopus、WOS、Medline和CINAHL数据库进行近十年的系统综述。这项研究包括对上肢和下肢阻力训练的研究。方法学质量采用PEDro量表进行分析,偏倚风险采用RoB2。结果:6项随机对照试验符合纳入条件,获得极好或良好的方法学质量。大多数重复变量是运动能力、生活质量和肌肉力量,在所有这些方面都发现了统计学上显著的积极结果。结论:力量训练对于COPD治疗似乎是安全有效的,可以改善运动能力、日常生活活动、肌肉力量、肺功能、生活质量和炎症水平。然而,关于这一主题的科学证据很少,未来有必要进行高质量的长期研究,以建立标准化的方案并评估COPD患者力量训练的持续益处。协议注册标识为CRD42024572717。
{"title":"Effects of strength training in patients with COPD: a systematic review.","authors":"María Barreiro Blanco, Clara Rodríguez-Gude, Iria Da Cuña-Carrera, Eva Lantarón-Caeiro","doi":"10.1080/17476348.2025.2562638","DOIUrl":"10.1080/17476348.2025.2562638","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms causing persistent, often progressive airflow obstruction. Strength training is a therapeutic option to prevent and/or reverse muscle dysfunction in COPD patients. Objective: to analyze the literature on the effects of strength training in COPD patients.</p><p><strong>Methods: </strong>A systematic review from the last ten years was conducted in August 2024 across PubMed, Scopus, WOS, Medline and CINAHL databases. The search included studies examining resistance training for upper and lower limbs. Methodological quality was analyzed using the PEDro scale and the RoB2 was used for risk of bias.</p><p><strong>Results: </strong>Six randomized controlled trials were eligible for inclusion, obtaining an excellent or good methodological quality. Most repeated variables were exercise capacity, quality of life and muscle strength, finding statistically significant positive results in all of them.</p><p><strong>Conclusions: </strong>Strength training appears to be safe and effective for COPD treatment, with improvements in exercise capacity, activities of daily living, muscle strength, lung function, quality of life and inflammatory levels. However, scientific evidence on this topic is scarce, and future high-quality, long-term studies are necessary to establish standardized protocols and assess the sustained benefits of strength training in COPD patients.<b>Protocol registration:</b> Identifier is CRD42024572717.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"189-197"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145081847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary issues in pediatric prehospital airway management. 儿科院前气道管理的当代问题。
IF 2.7 Pub Date : 2026-02-01 Epub Date: 2025-09-22 DOI: 10.1080/17476348.2025.2562632
Henry E Wang, Matthew Hansen, Manish I Shah, Nichole Bosson, John M VanBuren, Barbara Wendelberger, Jennifer Frey, Alexander Keister, Roger J Lewis, Marianne Gausche-Hill

Introduction: Airway management is one of the most important interventions performed by paramedics in the prehospital setting. While the standard of care for over 40 years, multiple studies highlight pitfalls associated with prehospital airway management in adults. Considerably less research describes prehospital airway management in children.

Areas covered: We searched PubMed for articles from 2000 to present using the keywords 'children,' 'airway management,' 'intubation intratracheal,' 'Emergency Medical Services,' and 'paramedic.' Studies highlight the pitfalls of adult prehospital endotracheal intubation such as tube misplacement and dislodgement, multiple and failed insertion attempts, interruptions in chest compressions, and inadvertent hyperventilation. Multicenter clinical trials including the PART and Airways-2 trials support the use of newer supraglottic airways as potential alternatives to intubation in adults. Only limited data describe prehospital airway management in children, including only one clinical trial performed 25 years ago.

Expert opinion: New studies are needed to guide paramedic pediatric airway management practices. The Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART) is an ongoing multicenter clinical trial that will provide critical new knowledge to guide prehospital pediatric airway management practices.

导言:气道管理是院前护理人员最重要的干预措施之一。虽然标准护理已超过40年,但多项研究强调了与成人院前气道管理相关的陷阱。相当少的研究描述院前气道管理的儿童。涵盖领域:我们用关键词“儿童”、“气道管理”、“气管内插管”、“紧急医疗服务”和“护理人员”在PubMed检索2000年至今的文章。研究强调了成人院前气管插管的缺陷,如管错位和脱位,多次插入失败的尝试,胸部按压中断,以及无意的过度通气。包括PART和airways -2试验在内的多中心临床试验支持使用新型声门上气道作为成人插管的潜在替代方法。只有有限的数据描述院前儿童气道管理,包括25年前进行的一项临床试验。专家意见:需要新的研究来指导护理人员的儿科气道管理实践。儿科院前气道复苏试验(Pedi-PART)是一项正在进行的多中心临床试验,将为指导院前儿科气道管理实践提供重要的新知识。
{"title":"Contemporary issues in pediatric prehospital airway management.","authors":"Henry E Wang, Matthew Hansen, Manish I Shah, Nichole Bosson, John M VanBuren, Barbara Wendelberger, Jennifer Frey, Alexander Keister, Roger J Lewis, Marianne Gausche-Hill","doi":"10.1080/17476348.2025.2562632","DOIUrl":"10.1080/17476348.2025.2562632","url":null,"abstract":"<p><strong>Introduction: </strong>Airway management is one of the most important interventions performed by paramedics in the prehospital setting. While the standard of care for over 40 years, multiple studies highlight pitfalls associated with prehospital airway management in adults. Considerably less research describes prehospital airway management in children.</p><p><strong>Areas covered: </strong>We searched PubMed for articles from 2000 to present using the keywords 'children,' 'airway management,' 'intubation intratracheal,' 'Emergency Medical Services,' and 'paramedic.' Studies highlight the pitfalls of adult prehospital endotracheal intubation such as tube misplacement and dislodgement, multiple and failed insertion attempts, interruptions in chest compressions, and inadvertent hyperventilation. Multicenter clinical trials including the PART and Airways-2 trials support the use of newer supraglottic airways as potential alternatives to intubation in adults. Only limited data describe prehospital airway management in children, including only one clinical trial performed 25 years ago.</p><p><strong>Expert opinion: </strong>New studies are needed to guide paramedic pediatric airway management practices. The Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART) is an ongoing multicenter clinical trial that will provide critical new knowledge to guide prehospital pediatric airway management practices.</p>","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"113-120"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12499907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breastfeeding, lung development and asthma. 母乳喂养、肺部发育和哮喘。
IF 2.7 Pub Date : 2026-02-01 Epub Date: 2025-08-11 DOI: 10.1080/17476348.2025.2546611
Sergio Verd
{"title":"Breastfeeding, lung development and asthma.","authors":"Sergio Verd","doi":"10.1080/17476348.2025.2546611","DOIUrl":"10.1080/17476348.2025.2546611","url":null,"abstract":"","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"105-108"},"PeriodicalIF":2.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144818903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert review of respiratory medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1